Skip to main content

Monitoring of C-Reactive Protein Using Ion Sensitive Field Effect Transistor Biosensor

Buy Article:

$107.14 + tax (Refund Policy)

An ion sensitive field effect transistor (ISFET) as a transducer, more precisely an immunologically modified-FET (immuno-FET) device, was utilized for the detection of the C-reactive protein (CRP), a potent marker for inflammation or cardiac risk. The ISFET biosensor investigated in this study was fabricated via a standard CMOS process. Anti-CRP monoclonal antibody was covalently attached to the gate surface using the self-assembled monolayer (SAM) method. The response of anti-CRP antibody to CRP was evaluated via the measurement of the electrical features of the ISFET device. As a consequence, a considerable reduction in drain current was clearly noted upon CRP binding to anti-CRP antibody on the gate, which can be explained by the charge effect, in which negatively charged CRP is predominantly responsible for the current drop in the n-type ISFET. The FET measurement was also verified by surface plasmon resonance (SPR) analysis. Collectively, our data convincingly showed that the FET-type biosensor is potentially applicable to the detection of CRP via antigen–antibody binding events on the gate surface.


Document Type: Research Article

Publication date: April 1, 2010

More about this publication?
  • The growing interest and activity in the field of sensor technologies requires a forum for rapid dissemination of important results: Sensor Letters is that forum. Sensor Letters offers scientists, engineers and medical experts timely, peer-reviewed research on sensor science and technology of the highest quality. Sensor Letters publish original rapid communications, full papers and timely state-of-the-art reviews encompassing the fundamental and applied research on sensor science and technology in all fields of science, engineering, and medicine. Highest priority will be given to short communications reporting important new scientific and technological findings.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content